|
|
|
| home > white papers > Personalised Medicine - Pharma and Dx Firms Share Wider Horizons - DiagnostikNet-BB |
|
|
 WHITE PAPERS |
|
DiagnostikNet-BB
|
|
Personalised Medicine - Pharma and Dx Firms Share Wider Horizons
|
|
Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
CLINICAL TRIALS SPECIALISTS COREX LOGISTICS APPOINTS NANA PEKHMASHVILI TO HEAD GEORGIA OFFICE
Georgian health industry expert Nana Pekhmashvili named as ‘Country Head, Georgia’
More info >> |
|
 |
White Papers |
 |
|
Customising the Cold Chain
World Courier
Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >> |
|
|
|
